Status:

RECRUITING

Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts

Lead Sponsor:

Ospedali Riuniti di Foggia

Conditions:

Autism Spectrum Disorder

ADHD

Eligibility:

All Genders

6-18 years

Phase:

NA

Brief Summary

In this interventional, pilot clinical trial investigators will stimulate the dorsolateral prefrontal cortex (DLPFC) in patients with Autism and ADHD. The goal of the study is to improve Cognition and...

Detailed Description

BACKGROUND ASD and ADHD are complex neurodevelopmental disorders with increasing prevalence worldwide. The neurobiology of ASD and ADHD reveals a complex picture of altered excitation-inhibition (E/I)...

Eligibility Criteria

Inclusion

  • Patients must have received a diagnosis of "ASD" or "ADHD" according to the Diagnostic and Statistical Manual of Mental Disorder-Fifth edition.
  • Patients must be older than 6-7 years of age, to obtain their collaboration easily

Exclusion

  • presence of known neurological or genetic conditions that are known to affect brain function and structure (i.e. brain tumors, X-fragile, tuberous sclerosis, etc.).
  • prescription of psychoactive medication(s) less than 4 weeks prior to joining the study.
  • medical history of head trauma associated with prolonged loss of consciousness.
  • presence of epilepsy, or history of previous epilepsy, seizures, and repeated febrile seizures.
  • presence of comorbidity with psychosis disorder.
  • presence of known endocrine, cardiovascular, pulmonary, liver, kidney, or other medical diseases.
  • vision and auditory impairment.
  • presence of diagnosed chronic or acute inflammation and/or infection.
  • lack of consent.

Key Trial Info

Start Date :

June 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06069323

Start Date

June 1 2023

End Date

June 1 2026

Last Update

October 5 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Neuropsychiatric Unit for Child and Adolescent, at General Hospital "Riuniti" of Foggia, University of Foggia

Foggia, Italy, 71122

Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts | DecenTrialz